TRJ Stock Overview
Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for TRJ from our risk checks.
Trajan Group Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$1.13 |
52 Week High | AU$1.91 |
52 Week Low | AU$0.98 |
Beta | 0.75 |
1 Month Change | 7.14% |
3 Month Change | -1.32% |
1 Year Change | -33.04% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -43.18% |
Recent News & Updates
Fewer Investors Than Expected Jumping On Trajan Group Holdings Limited (ASX:TRJ)
Mar 01What Does Trajan Group Holdings Limited's (ASX:TRJ) Share Price Indicate?
Sep 24Recent updates
Fewer Investors Than Expected Jumping On Trajan Group Holdings Limited (ASX:TRJ)
Mar 01What Does Trajan Group Holdings Limited's (ASX:TRJ) Share Price Indicate?
Sep 24Little Excitement Around Trajan Group Holdings Limited's (ASX:TRJ) Revenues As Shares Take 26% Pounding
Sep 09Earnings Miss: Trajan Group Holdings Limited Missed EPS By 86% And Analysts Are Revising Their Forecasts
Aug 29Are Investors Undervaluing Trajan Group Holdings Limited (ASX:TRJ) By 28%?
Jun 05Some Investors May Be Willing To Look Past Trajan Group Holdings' (ASX:TRJ) Soft Earnings
Sep 02Calculating The Intrinsic Value Of Trajan Group Holdings Limited (ASX:TRJ)
Feb 23Shareholder Returns
TRJ | AU Life Sciences | AU Market | |
---|---|---|---|
7D | -4.3% | -6.2% | -3.0% |
1Y | -33.0% | -13.9% | 3.9% |
Return vs Industry: TRJ underperformed the Australian Life Sciences industry which returned -13.9% over the past year.
Return vs Market: TRJ underperformed the Australian Market which returned 3.9% over the past year.
Price Volatility
TRJ volatility | |
---|---|
TRJ Average Weekly Movement | 10.5% |
Life Sciences Industry Average Movement | 10.5% |
Market Average Movement | 8.9% |
10% most volatile stocks in AU Market | 17.2% |
10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: TRJ has not had significant price volatility in the past 3 months.
Volatility Over Time: TRJ's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 600 | Stephen Tomisich | www.trajanscimed.com |
Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. It operates through Analytical Products and Life Science Solutions segments. The company offers analytical products, including syringes, GC columns and connections, rings, inlet liners, emitters, purifiers and filters, and tubing products; pathology products, such as NBF containers, adhesive and frosted microscope slides, coverslips, slide storage trays/mailers, cassette storage boxes, biopsy pads, histology wax plus, microtome blades, and marking dyes and sets, as well as MiPlatform, a smartphone adapter.
Trajan Group Holdings Limited Fundamentals Summary
TRJ fundamental statistics | |
---|---|
Market cap | AU$171.24m |
Earnings (TTM) | -AU$1.67m |
Revenue (TTM) | AU$158.50m |
1.1x
P/S Ratio-102.2x
P/E RatioIs TRJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TRJ income statement (TTM) | |
---|---|
Revenue | AU$158.50m |
Cost of Revenue | AU$95.21m |
Gross Profit | AU$63.29m |
Other Expenses | AU$64.97m |
Earnings | -AU$1.67m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.011 |
Gross Margin | 39.93% |
Net Profit Margin | -1.06% |
Debt/Equity Ratio | 38.3% |
How did TRJ perform over the long term?
See historical performance and comparison